Enlivex Therapeutics Statistics

Total Valuation

TLV:ENLV has a market cap or net worth of ILS 78.33 million. The enterprise value is -2.10 million.

Market Cap	78.33M
Enterprise Value	-2.10M

Important Dates

The next estimated earnings date is Friday, June 13, 2025.

Earnings Date	Jun 13, 2025
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	23.85M
Shares Outstanding	n/a
Shares Change (YoY)	+10.44%
Shares Change (QoQ)	+5.70%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	20.97M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
PB Ratio	0.91
P/TBV Ratio	0.91
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	0.04
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	0.04

Financial Position

The company has a current ratio of 6.84, with a Debt / Equity ratio of 0.02.

Current Ratio	6.84
Quick Ratio	6.56
Debt / Equity	0.02
Debt / EBITDA	n/a
Debt / FCF	-0.04
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -55.95% and return on invested capital (ROIC) is -35.16%.

Return on Equity (ROE)	-55.95%
Return on Assets (ROA)	-30.10%
Return on Invested Capital (ROIC)	-35.16%
Return on Capital Employed (ROCE)	-65.04%
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	n/a
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -36.88% in the last 52 weeks. The beta is 0.76, so TLV:ENLV's price volatility has been lower than the market average.

Beta (5Y)	0.76
52-Week Price Change	-36.88%
50-Day Moving Average	360.82
200-Day Moving Average	431.09
Relative Strength Index (RSI)	41.40
Average Volume (20 Days)	19,914

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	0.95

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-56.59M
Pretax Income	-54.69M
Net Income	-54.69M
EBITDA	-54.60M
EBIT	-56.59M
Earnings Per Share (EPS)	-2.67

Full Income Statement

Balance Sheet

The company has 85.58 million in cash and 1.94 million in debt, giving a net cash position of 83.63 million.

Cash & Cash Equivalents	85.58M
Total Debt	1.94M
Net Cash	83.63M
Net Cash Per Share	n/a
Equity (Book Value)	85.92M
Book Value Per Share	3.63
Working Capital	80.84M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -47.38 million and capital expenditures -375,157, giving a free cash flow of -47.75 million.

Operating Cash Flow	-47.38M
Capital Expenditures	-375,157
Free Cash Flow	-47.75M
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

TLV:ENLV does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-10.44%
Shareholder Yield	n/a
Earnings Yield	-69.82%
FCF Yield	-60.97%

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	n/a